For the study, researchers reviewed the anonymised medical records of 2,040 chelonia on the College's VetCompass database.
94.26% were recorded as tortoises, 3.63% terrapins and 2.11% turtles.
The most common tortoise species were Hermann’s tortoise, Horsfield’s tortoise and Mediterranean spur-thighed tortoise, while the most common terrapin species were musk turtle and yellow belly slider.
The study found that the most common disorders in tortoises were beak abnormality (17.68%), overgrown nails (11.91%) and shell abnormality (9.67%), while the most common disorders in terrapins were top and bottom shell abnormalities (13.51%).
The researchers say that most of these disorders are externally visible making them easier to recognise and diagnose, however they also often correspond with inappropriate husbandry and can be related to internal diseases that are harder to identify and diagnose.
The average age of death in the study was found to be 7.32 years, which is below the expected lifespan of most species of tortoise, suggesting that many are dying prematurely.
Dr Jessica May Hornby, exotic veterinary surgeon and lead author of the study, said:
“This research has provided us with a base to start to understand what veterinarians are currently seeing in practice and therefore give an insight into the health of the chelonian population.
"People are no longer only keeping the more common species of pets, such as dogs and cats, so this data is vital to understanding where and how owners and veterinarians need further support and training to ensure these brilliant little guys get the veterinary care they need, especially when many should easily be outliving us!”
Reference
Photo: www.depositphotos.com
The range includes a spray, collars and diffusers.
Unlike many other pheromone diffusers which need to be plugged into a wall socket, Virbac's uses a patent-pending slow release technology which doesn't need power.
Virbac says the new range has been scientifically proven with published studies which demonstrate not only their effectiveness in managing stress-related behaviours in dogs and cats, but also an equivalent and superior efficacy to the current market leading pheromone products 1,2,3
Andrew Connolly, Virbac's Marketing Director for the UK and Ireland said: "Veterinary professionals have a crucial role to play in supporting their clients with the behavioural management of their pets, both when visiting the practice and at home, and the benefits of pheromones in helping to manage dog and cat behaviour are already very well recognised."
"With Zenidog and Zenifel we hope to make pheromone therapy easier, more cost-effective and better for the environment."
Zenidog and Zenifel are available to order from NVS, Covetrus and VSSCo now.
References
Launching this spring, CVS says it's the only programme of its type in the veterinary sector.
The programme will be open to all of CVS's young vets and will operate within all 12 of its farm practices in the England, Scotland and Northern Ireland.
Each CVS farm graduate vet will be able to go on an exchange in their second year of the programme and every placement will last up to two weeks.
The subject matter of each exchange will be at the direction of the graduate rather than following a specific programme, so participating graduates have the freedom to explore their own areas of interest.
Anna Bruguera Sala, Programme Co-ordinator and vet at Alnorthumbria Farm Vets, said: “The major benefits of our new graduate exchange programme is that it is open to all young vets of different levels of experience and provides bespoke learning opportunities tailored to each individual.
"It will also create connections, so experienced colleagues can support an exchange student with their new skillset when they are back within their own practice.”
www.careerswithcvs.co.uk
Anyone - clients, colleagues or mentors - can nominate a young vet who they think has exceptional clinical skills, a particular passion for equine welfare or great leadership skills.
To be eligible nominees need to be members of BEVA, have graduated within the past seven years and be a registered professional with the appropriate body (eg RCVS).
BEVA Council Member Gemma Dransfield said: “We all know that one superstar who's brilliant with patients, fantastic with clients, and just an all-round legend in the making."
“This is your chance to give them the recognition they deserve.
"The BEVA One To Watch Award recognises those who are shaping the future, setting new standards in equine care, and driving the next generation of equine veterinary excellence.
"Not only will they have the glowing accolade of winning, but they will also win some career-boosting perks.”
To put an individual forward for consideration, a seconder is needed and either the nominator or seconder must be a BEVA member.
All nominations will be reviewed by a panel of experts comprising a BEVA Careers Committee representative, a senior equine vet, a non-equine veterinary professional and an external industry representative or client.
Up to five finalists will be selected and invited for a friendly online chat with the judging panel.
The winner will be announced at BEVA Congress and will be presented with a trophy, one year of BEVA membership, a fully paid BEVA Congress experience (including a one-day pass, overnight stay, and ticket to the annual dinner) and an exclusive career-boosting opportunities with BEVA to help take their career to the next level.
All finalists will receive a one-day ticket to BEVA Congress.
www.beva.org.uk/About-us/What-we-do/BEVA-Awards/One-to-watch
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
The increase has prompted a call by Equine Infectious Disease Surveillance (EIDS) for equine professionals and owners to strengthen biosecurity and consider vaccination to help reduce disease spread.
EIDS has been monitoring diagnoses reported to SES and says the data indicates a genuine increase rather than normal year-to-year variation.
With the number of confirmed cases climbing, EIDS and the SES network are urging veterinary professionals and horse owners to revisit their yard management practices, saying that simple but consistent actions, such as isolating new arrivals, disinfecting shared equipment, and post-outbreak screening can make a substantial difference in controlling the disease.
In addition, they recommend the Strangvac vaccine, saying that when combined with good hygiene and daily temperature checking, can help reduce both the risk of infection and onward spread.
Dr Richard Newton of EIDS said, “These findings are a clear reminder that strangles remains an ever-present risk to the UK horse population.
"The increase in diagnoses underlines the importance of continued vigilance, prompt reporting, and proactive prevention measures.”
https://equinesurveillance.org/ses/
Dr Butterworth’s practice was a member of TBAS, a Department of Environment, Food and Rural Affairs-funded (Defra) project administered by Farmcare Solutions Ltd which provides advice to eligible farmers via its veterinary partners.
The farm to which the charges relate to was owned by Dr Bexon’s partner. It had no cattle on-site (though was still eligible for the TBAS).
Dr Butterworth was charged with signing a TBAS visit report, in which he was named as the TBAS advisor, relating to a visit to the farm in February 2023 which had, in fact, not taken place and then subsequently signed a report about a follow-up visit in July 2023 which also hadn’t taken place.
Dr Bexon was charged with signing the same two false reports as a representative of the farm in question.
Both faced a secondary charge that their actions were dishonest, misleading and risked undermining procedures relating to public health and animal welfare.
Dr Butterworth and Dr Bexon admitted all the charges against them and that these charges amounted to serious professional misconduct.
The Committee also found that their actions amounted to serious professional misconduct in that they had breached three of the five key principles in the Code of Professional Conduct relating to: honesty and integrity; client confidentiality and trust; and professional accountability.
The Committee also found that the actions of both veterinary surgeons had breached the ’10 principles of certification’ outlined in the supporting guidance to the Code.
Considering Mr Butterworth’s conduct, the Committee found that there were a number of aggravating factors including: the premeditated nature of the conduct as he was the driving force behind the deceit, the fact there was financial gain as his practice would have been paid for the non-existent visits, breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and abuse of professional position as a TBAS advisor.
For Dr Bexon the aggravating factors were breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and the fact that, as a TBAS advisor, she should have known that physical visits to farms within the scheme were mandatory.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee considered both respondents’ conduct was liable to have a seriously detrimental effect on the reputation of the profession and undermined public confidence in the profession and the TBAS process.
"The Committee considered that members of the public would be deeply troubled that registered veterinary surgeons had behaved in this way.”
At the hearing the Committee received a large number of positive testimonials for Dr Butterworth, including three given directly to the Committee – one from a veterinary surgeon colleague and two from farmer clients.
The Committee also considered his lack of previous disciplinary history and otherwise unblemished career, open and frank admissions at an early stage, insight into his misconduct, genuine remorse and positive reflection, efforts to avoid a repetition of behaviours and evidence of a more mature approach to management, lapse of time since the incident.
Taking everything into account the Committee decided reprimanding Dr Butterworth and warning him with regard to future conduct was the most appropriate and proportionate response.
Paul added: “The Committee did give serious consideration to suspending Dr Butterworth’s registration with the College.
"Such a sanction would have sent out a clear message that this sort of behaviour is absolutely not to be tolerated.
"However, in light of the extensive mitigation, his honesty and significant insight throughout these proceedings and the unlikeliness of behaviour of this type ever being repeated, the Committee considered the public would not be best served by suspending an otherwise exemplary veterinary surgeon and that such a sanction would be disproportionate and punitive.”
"In such circumstances, the Committee was satisfied that a reprimand and warning not to behave in this way again, would provide adequate protection to animals and would satisfy the public interest.
"The Committee was persuaded that Dr Butterworth would be most unlikely to make such a flawed set of decisions again.
"Notwithstanding the serious nature of Dr Butterworth’s conduct, the Committee was satisfied that a fully informed member of the public would not be shocked if he were allowed to continue to practise.”
The Committee also received a significant number of positive testimonials for Dr Bexon, with three veterinary surgeon colleagues giving oral evidence to the Committee.
The Committee also considered her lack of disciplinary history and hitherto unblemished career, her open and frank admissions, her insight, remorse and positive reflections, her efforts to avoid repetition of the behaviours and the lapse of time since the event.
Taking everything into account, the Committee decided to reprimand Dr Bexon.
Paul said: “This was not a case where she had been motivated by any financial gain.
"Indeed, everything the Committee had read and heard about her indicated the opposite and furthermore, it was apparent that she had nothing to gain by her actions beyond satisfying Dr Butterworth.
"As already stated, the Committee acknowledged that the role played by Dr Bexon was less than that played by Dr Butterworth.
"Moreover, there was a power imbalance at play and Dr Butterworth was able to take advantage of, albeit unknowingly, Dr Bexon’s lack of self-confidence.”
"The Committee has already indicated that it believed the likelihood of her repeating such behaviour to be non-existent.
"Her significant insight, together with the reflection and remedial work she has undertaken are as much as any person could do.
"She had truly learnt her lesson in the harshest of ways.
"In the Committee’s view she did not represent any risk to animals or the public, indeed quite the contrary as she is a very able vet, in high demand by her clients.”
www.rcvs.org.uk/disciplinary
Leah won the award for her extraordinary dedication, compassion, unwavering devotion to her patients and professionalism in all aspects of her work, both in practice and outside it.
After graduating from the University of Edinburgh in 2021, Leah began working as a mixed practice vet at Flett and Carmichael Veterinary Surgeons in Orkney, where she always goes the extra mile for her patients, whether within her practice or out and about in the Orkney countryside and coastline.
She is involved with multiple charities outside of work, becoming an Orkney Nature Festival trustee, a British Divers Marine Life Rescue (BDMLR) medic and Scottish Marine Animal Stranding Scheme volunteer.
Her involvement is not confined to daylight hours or predictable situations as she frequently responds to emergency call-outs for seals, porpoise or dolphins at all hours, often in challenging conditions.
It is not uncommon for her to be found on windswept beaches in the dead of night, providing expert care to stranded or injured marine mammals.
She has also been involved in providing first aid to stranded whales and dolphins and assisting in their re-floatation or euthanasia when the animals can’t be refloated due to illness and also assisted with 37 pilot whale postmortems on Sanday, Orkney, in 2024 after the most significant mass stranding event in the UK in the last 100 years.
Leah said: “I am very humbled to even be nominated, let alone win this award, especially when I know how many amazing and talented young vets there are in the UK.
"I truly do love the work that I do, island vetting really is unique and I’m grateful to have the opportunity to help make a difference.”
Rachel Dean won her award for her significant contribution to clinical practice and veterinary education.
Since graduating from the University of Glasgow, she has worked in mixed, dairy and small animal general practice in the private, charity and academic sectors.
"She is passionate about veterinary healthcare and is a recognised international leader of evidence-based veterinary medicine and encourages authentic collective clinical leadership and progressing care through developing professional connections, research, innovation, quality improvement and professional development.
BVA President Rob Williams said: “Rachel's work on evidence-based veterinary medicine (EBVM), including founding the Centre for Evidence-based Veterinary Medicine at University of Nottingham’s School of Veterinary Medicine, has been truly pioneering and she is an impressive educator, having delivered education and mentoring in the fields of feline and shelter medicine.”
Andrew Cunningham won his award for his exceptional contributions to the advancement of veterinary medicine and the field of wildlife veterinary science.
Andrew is currently Deputy Director of Science at ZSL, where he has worked in various roles since 1988.
He has led several national and international, multi-disciplinary wildlife disease research projects investigating the emergence, spread, impact and mitigation of disease threats to wildlife conservation, understanding the role of anthropogenic environmental change on wildlife disease emergence.
His large body of original, high-quality research has had major impacts across conservation biology, veterinary science and public health, informing and influencing the policies of governments, intergovernmental organisations and NGOs.
Polly Compston received her award for her outstanding contribution to animal health and welfare on a global scale.
After graduating from Edinburgh Vet School, Polly worked in mixed and small animal practice before completing a residency in clinical research at Rossdales Equine Hospital alongside an MSc in Veterinary Epidemiology and Public Health.
She went on to work in research for an NGO, developing an evidence base for animal welfare interventions across Asia, Sub-Saharan Africa, and Latin America, and later completed a PhD on the economic and social drivers of foot-and-mouth disease control in Kenya.
She currently has two roles, one as Veterinary Head of Outbreak Central Services at the Animal and Plant Health Agency (APHA), leading licensing, tracing and surveillance teams in the UK’s response to notifiable disease outbreaks, and also as a Technical Lead at EuFMD supporting international efforts for improved transboundary livestock disease control.
Finally, Pet People Vets, 387 Vets and Brooke Action for Working Horses and Donkeys all won a Wellbeing Award for going above and beyond to support staff wellbeing.
Congratulations to one and all!
The Seller’s Declaration has been revised with the support of British Equestrian (BEF) and British Horse Society (BHS) to make the purchase process more efficient for both buyer and seller.
BEVA says the new Declaration is a more extensive, stand-alone document which the buyer should request from the seller directly before the formal process of the PPE commences.
In this way the seller is obliged to disclose any pertinent information, such as previous lameness, stereotypies, specific management requirements, previous veterinary interventions and details of preventative dental care and worm control, prior to the PPE proceeding.
Lucy Grieve, Veterinary Projects Officer at BEVA, said: “BEVA’s new Seller’s Declaration will iron out the PPE process to make it smoother and more efficient for all three parties involved: buyer, seller and vet.
“The advantage is it cuts out the vet as a middleman… asking if the horse has received any medication, or coughs on dry hay and so on.
“The new Seller’s Declaration means that the seller should declare those things to the buyer straight off.
"If completed in advance, it should give the buyer more robust information on which to base proceeding with the PPE or not.”
https://www.beva.org.uk/Resources/Clinical-resources/PPE-toolkit
The company says the new framework is designed to help veterinary teams make prescribing decisions which balance animal welfare, public health, and environmental sustainability, the latter especially in the light of recent research which found significant levels of imidacloprid and fipronil - which are toxic to invertebrates - in waterways1,2.
The Lifestyle Parasite Risk Assessment considers the following factors before recommending treatment, including:
Alongside the new assessment, CVS has launched a training course for all staff who interact with parasiticides, so they can confidently explain the benefits of lifestyle-based prescribing.
The CMA provisional decision was widely seen as less interventional than had been expected, largely demanding transparency over things like pricing, practice ownership and billing, which many practices had already implemented.
However, one provisional decision was that regardless of their status, all veterinary practices should inform owners that they can ask for a written prescription and explain that they may be able to have it fulfilled cheaper online.
Two of the largest online veterinary pharmacies are animed.co.uk, which is owned by CVS, and peddrugsonline, which is owned by IVC.
So in effect, the decision asked independent practices to direct their clients to competitor businesses.
What you might call a bitter pill to swallow.
In the light of the announcement, CVS issued a press release citing the "clarity" afforded by the CMA announcement and the fact that it does not think the CMA's proposed remedies will have a material impact, as factors behind its decision to seek a Main Market listing.
The company has also announced a £20m share buyback programme.
The Clinical Research Project grants support the undertaking for small-scale research projects in companion animals, with the ultimate objective of advancing understanding of the causes and/or management of a clinical disorder.
The awards include funding for:
The projects are expected to be completed by 2028.
https://bsava.com/petsavers
The company is hosting 14 sessions over the two days, delivering over 8 hours of CPD
Speakers include Tara Ryan, CVS Chief Veterinary Officer, Laurent Garosi, Clinical Director of Vet Oracle Teleradiology, Kieran Borgeat, Specialist in Veterinary Cardiology at Bristol Vet Specialists, Emma Cooper, Head Veterinary Surgeon at Bell Equine, Alan Johnson, Regional Clinical Lead at CVS and Mark Moreton, CVS Director of Learning & Development.
Clinical topics will range from bone marrow biopsies and neurological examinations, to emergency diagnostics and perioperative analgesia.
Professional discussions will focus on clinical freedom or clinical guidance, and why career progression is more than certificates or practice ownership.
Leadership and management sessions will cover supporting new graduates and adopting the right coaching mindset.
Mark Moreton said: “Whether you're a vet, nurse, practice manager or student - there’s something here for everyone.
"CVS Learning Live is designed to help our veterinary colleagues grow, connect, and thrive.
"It reflects our ongoing mission to help every colleague reach their full potential through accessible, high-quality education and peer support.
"We encourage delegates to plan their sessions in now so that they don’t miss out.”
https://london.vetshow.com/conference-programme.
The project aims to produce evidence to help reduce the risk of musculoskeletal injury, one of the leading causes of morbidity and mortality in racehorses worldwide.
The researchers say that despite significant advances in understanding of injuries that occur in horses on a racecourse, there is currently limited information on injuries that happen during training.
The study aims to identify modifiable risk factors and inform practical, evidence-based recommendations for trainers and equine vets.
Over a three-year period, the RVC-led research team will conduct prospective cohort studies in flat and national hunt (jump) thoroughbreds in training.
The researchers will estimate the incidence of the most common types of musculoskeletal injuries in racehorses in training, including fracture and tendon and joint injuries, develop novel measures of training workload that can be used to monitor training over time, and investigate how training regimes can be optimised to reduce the risk of exercise-induced injury.
The study will also trial the use of wearable technology to establish its practical usefulness for large-scale application in measuring horses’ training workload.
Professor Kristien Verheyen, Professor of Veterinary Clinical Epidemiology at the RVC, said: “This large-scale study will fill key knowledge gaps on injury occurrence in racehorses in training.
"Its findings will directly impact racehorse welfare by identifying opportunities for intervention based on ‘best practice’ in current training regimens to reduce the likelihood of injury.”
https://www.rvc.ac.uk/research/projects/training-injury-prevention-study
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
Purina says it is common for dogs with gastrointestinal disturbances not to digest fat properly1, resulting in water secretion in the gut and loose stools2, production of anti-inflammatory compounds2 and altered microbiome composition 3,4.
The company says a limited fat diet can help, but some conditions, such as hyperlipidaemia, require even lower fat levels, such as found in the new EN Low Fat diet.
If you go to stand P20 and watch a short video about the new diet, you'll be entered into a draw to with prizes which include shopping vouchers, gym bags and umbrellas.
Vets from the Purina Technical Support Line will also be on the stand to answer questions about the new product.
Finalists are chosen by a panel of industry leaders on the basis that they embody the qualities that define veterinary excellence: compassion, teamwork, innovation and a relentless commitment to animal welfare.
The finalists this year are:
Vet of the Year
Vet Nurse of the Year
Practice Support Staff of the Year
Practice of the Year
The winners will be announced at the London Vet Show on Thursday 20th.
Good luck, one and all!
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet.
Do you have an interesting or unusual small animal medicine case that would be suitable to present as an oral abstract? The Small Animal Medicine Society (SAMSoc) is currently inviting submissions for the case report session during the pre BSAVA satellite meeting on April 1st 2009.
This Competition is open to anyone with an interest in canine or feline medicine. Suitable cases should have interesting discussion points but need not necessarily be so unusual that they would be considered publishable.
Three case reports will be selected by the SAMSOC committee for presentation during the meeting (12 minutes plus 3 minute for questions).
Successful selection entitles the author to free registration for the meeting.
At the end of the session the audience will vote by ballot for their favourite case report. Each presenter will then be awarded a prize which has been kindly donated by Vetoquinol: 1st place £300, 2nd place £150, 3rd place £50.
If you are interested in submitting a case report for consideration please contact Alison Ridyard (Alison.Ridyard@ed.ac.uk.) for details.
The deadline for submission is February 1st 2009
We're delighted to announce details of the SAMSoc Pre-BSAVA Satellite Meeting:
Date: Wednesday April 1st 2009Venue: Hall 8a, ICC, Birmingham
Timetable:
8.30 - 9am
Registration
9 - 10
Thoracic CT
Charlotte Whatmough (UK)
10 - 11
Thoracoscopy for medics
Eric Monnet (USA)
11 - 11.30
Break
11.30-12.15
Case Reports - sponsored by Vetoquinol
12.15 - 1.15
Current management of Diabetes Mellitus in people
Dr Aldibbiat (UK)
1.15 -2.30
Lunch
2.30-3.30
A logical approach to changed mental status
Natasha Olby (USA)
3.30-4.30
Interpretation of bone marrow cytology
Reinhard Mischke (Germany)
4.30-5pm
AGM
Satellite meeting fees (lunch is included) - members £65, Non members £95. SAMSOC annual membership - £25
We would like to invite submission of interesting case reports. There will be three presentations each lasting 12 minutes (plus 3 minutes for questions). If you have a case that you would like to present please e-mail an outline (up to 500 words) to Alison.Ridyard@ed.ac.uk by the 1st February 2009. The programme co-ordinators will review the submissions and inform people of the selected cases by the 1st March 2009. This is a chance for sharing your interesting and unusual cases with the group and we look forward to some interesting submissions. This year in addition to free registration, there will be prizes for the best case reports (first prize £300, second £150 , third £50).
If you are interested in joining the society or attending the meeting contact medicinereferrals@hotmail.com or iab@vetspecialists.co.uk. You may also click here for more details.
We would like to announce a new facility in the SAMSoc website. We are inviting members to list details of any clinical trials that they are currently undertaking, within the SAMSoc Wiki.
Our hope is that by distributing this information to our members, case recruitment for your study will increase. It may also lead to collaboration with other groups.
In time, it will also build into a valuable, searchable database of research work carried out by our members.
After completion and successful publication of any trails you have posted, we would appreciate it if you could post an abstract of the work (within the Wiki with an appropriate journal citation) for our members to view.
Details of how to upload your trail data and the information required in the post can be found in the Wiki section of the SAMSoc page (you will find Wiki in the quick links menu on the right of the page). If you have any problems please contact us.
A "News" feature will be distributed intermittently to all members to summaries deatils of recently posted trails
Our first research post is from Stijn Niessen of the RVC. He is inviting vets, nurses and owners to complete a short questionnaire on patients undergoing therapy for diabetes mellitus. Further details on how to source the questionnaires can be found in his post in the SAMSoc Wiki.
Brain Catchpole and Lucy Davidson are collaborating with a number of centres to investigate the genetic basis of several canine endocrine disorders.They are keen to recruit samples (serum and EDTA blood) from dogs suffering from the following disorders:
· neonatal diabetes mellitus (i.e. diabetes onset < 1 yr of age)
· diabetes in high risk breeds (Samoyed, Cairn terrier, Tibetan terrier, Polish Lowland Sheepdog)
· dioestrus diabetes
· lymphocytic thyroiditis / hypothyroidism
· hypoadrenocorticism
Further details can be found in the WIKI of the SAMSOC website
Other projects posted on the SAMSOC website
Stijn Nelson’s Diabetes Treatment Survey for vets, nurses and owners – further details for case recruitment can be found in the WIKI
If you would like to announce recruitment details for a clinical trial, please logo onto to the SAMSoc Wiki or contact a member of the SAMSOC committee.
If you wish to register for the SAMSoc pre-BSAVA meeting on April 2009 then please print the attached form and send the completed form and payment to the address shown.
Please note that the deadline for catering arrangements is March 13th. Lunch will only be provided to those who have registered and paid before this date!
After a record number of submissions we are please to announce that the 3 finalists have been selected. In no particular order they are
The cases will be presented during the SAMSOC day and audience voting will select the winner.
Registration forms and the speaker schedule for the SAMSOC meeting 1st April 2009 can be found on the website ( alternatively contact medicinereferrals@hotmail.com or iab@vetspecialists.co.uk ).
Note - we are unable to provide a lunch for registrations received after March 12th